Strategy consulting firm focused on pharma/biotech. Provides clinical development strategy,commercial forecasting,portfolio optimization,and market access consulting.
Vendor description
Life sciences strategy consulting
Clinical development strategy,Commercial assessment,Portfolio optimization,Market access
- Deep pharma/biotech expertise
- Commercial strategy
- M&A due diligence
- Market access consulting
- Strategy only (no operational trial execution)
- Premium pricing
- Primarily US/EU
Approved customer reviews
Write a reviewNo reviews yet
Be the first customer to share verified experience with this vendor.
Pricing
$
Key facts
| HQ country | United States |
|---|---|
| Geography | Global |
| Service model | Consulting |
| Study phases | Phase I, Phase II, Phase III, Phase IV |
| Trial scale | Medium,Large |
| Therapeutic areas | Oncology, Rare diseases, Immunology, Cell and Gene Therapy, Neurology |
Related vendors
Editorial ranking
See how Putnam Associates compares - best Specialist CRO vendors for clinical trials.